Antioxidant therapy in multiple sclerosis

Area of Science:

• Neuroscience
• Immunology
• Biochemistry

Background:

• Reactive oxygen species (ROS) are implicated in multiple sclerosis (MS) pathology, including blood-brain barrier dysfunction and lesion development.
• Oxidative stress from ROS contributes to inflammatory and autoimmune tissue destruction in the central nervous system.
• The central nervous system has natural antioxidant defenses, but these may be insufficient in MS.

Purpose of the Study:

• To review the therapeutic efficacy of antioxidant interventions for multiple sclerosis (MS).
• To evaluate the role of ROS in MS pathogenesis and the potential of antioxidant therapy.

Main Methods:

• Literature review of studies on ROS, oxidative stress, and antioxidants in MS.
• Analysis of in vitro and in vivo experimental data, including animal models of MS (e.g., experimental autoimmune encephalomyelitis - EAE).
• Examination of available clinical data on antioxidant treatments in MS patients.

Main Results:

• ROS mediate key pathological events in MS, such as monocyte migration and blood-brain barrier disruption.
• Antioxidant therapies have demonstrated benefits in preclinical MS models.
• Some antioxidants showed efficacy in preventing or reducing EAE progression in experimental studies.

Conclusions:

• Antioxidant therapy is a potential therapeutic strategy for multiple sclerosis (MS) due to the role of ROS in disease progression.
• Further clinical research is needed to establish the efficacy and safety of specific antioxidant treatments in MS patients.